Fabrice Egros
Corporate Officer/Principal bei LUPIN LIMITED
Profil
Fabrice Egros is currently the Chairman at Multicare Pharmaceuticals Philippines, Inc., Chairman at Kyowa Criticare Co. Ltd., Director at Biotechnology Innovation Organization, Director at Generic Health Pty Ltd., Director at YL Biologics Ltd., and President-Corporate Development & Growth Markets at Lupin Ltd.
He previously worked as the Deputy Chief Executive Officer, COO & Director at NovaMedica LLC, Chairman at Kyowa Pharmaceutical Industry Co., Ltd., Independent Director at Syndax Pharmaceuticals, Inc., SVP-Corporate Business Development & Strategy at UCB SA, Chief Operating Officer at Xanodyne Pharmaceuticals, Inc., SVP-Corporate Business Development & Strategy at UCB Pharma, Inc., Vice President at Sanofi-Aventis U.S.
LLC, President at UCB, Inc., and President at UCB Japan Co. Ltd.
Dr. Egros has an undergraduate degree from Harvard University, a graduate degree from the University of Orsay, and undergraduate and doctorate degrees from the University of Chatenay-Malabry.
Aktive Positionen von Fabrice Egros
Unternehmen | Position | Beginn |
---|---|---|
LUPIN LIMITED | Corporate Officer/Principal | 01.10.2015 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | - |
Generic Health Pty Ltd.
Generic Health Pty Ltd. Pharmaceuticals: MajorHealth Technology Generic Health Pty Ltd. manufactures and sells pharmaceutical products. It offers generic prescription tablets, pharmacy action, goanna range of therapeutic oils and rubs, and hospital injectable products. The company was founded by Gavin Upiter in 2004 and is headquartered in Camberwell, Australia. | Direktor/Vorstandsmitglied | - |
Multicare Pharmaceuticals Philippines, Inc.
Multicare Pharmaceuticals Philippines, Inc. Pharmaceuticals: MajorHealth Technology Part of Lupin Ltd., Multicare Pharmaceuticals Philippines, Inc. is a pharmaceutical company based in Makati City, Philippines. The Filipino company prioritizes understanding the needs of its customers and offers a wide range of therapeutic products to contribute to family healthcare. Multicare Pharmaceuticals Philippines was acquired by Lupin Ltd. on March 26, 2009. | Vorsitzender | - |
Kyowa Criticare Co. Ltd.
Kyowa Criticare Co. Ltd. Medical DistributorsDistribution Services Kyowa Criticare Co. Ltd. manufactures and sells ethical drugs. It also offers contract manufacturing of ethical drugs. The company was founded in April 1941 and is headquartered in Tokyo, Japan. | Vorsitzender | - |
YL Biologics Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Fabrice Egros
Unternehmen | Position | Ende |
---|---|---|
SYNDAX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 23.02.2022 |
NovaMedica LLC
NovaMedica LLC Pharmaceuticals: MajorHealth Technology NovaMedica LLC operates as a pharmaceutical company. Its portfolio includes gastroenterology, ophthalmology, and neurology. The company was founded in 2012 and is headquartered in Moscow, Russian Federation. | Geschäftsführer | 01.09.2015 |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Geschäftsführer | - |
░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Fabrice Egros
Harvard University | Undergraduate Degree |
University of Orsay | Graduate Degree |
University of Chatenay-Malabry | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SYNDAX PHARMACEUTICALS, INC. | Health Technology |
UCB | Health Technology |
LUPIN LIMITED | Health Technology |
Private Unternehmen | 12 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Health Technology |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Kyowa Pharmaceutical Industry Co., Ltd.
Kyowa Pharmaceutical Industry Co., Ltd. Pharmaceuticals: MajorHealth Technology Kyowa Pharmaceutical Industry Co., Ltd. develops, manufactures, and markets pharmaceutical products. It offers tranquilizers, hypnotics, vasodilators, bronchial dilators, and anti-ulcer agents. The company was founded on January 29, 1954 and is headquartered in Osaka, Japan. | Health Technology |
Generic Health Pty Ltd.
Generic Health Pty Ltd. Pharmaceuticals: MajorHealth Technology Generic Health Pty Ltd. manufactures and sells pharmaceutical products. It offers generic prescription tablets, pharmacy action, goanna range of therapeutic oils and rubs, and hospital injectable products. The company was founded by Gavin Upiter in 2004 and is headquartered in Camberwell, Australia. | Health Technology |
Multicare Pharmaceuticals Philippines, Inc.
Multicare Pharmaceuticals Philippines, Inc. Pharmaceuticals: MajorHealth Technology Part of Lupin Ltd., Multicare Pharmaceuticals Philippines, Inc. is a pharmaceutical company based in Makati City, Philippines. The Filipino company prioritizes understanding the needs of its customers and offers a wide range of therapeutic products to contribute to family healthcare. Multicare Pharmaceuticals Philippines was acquired by Lupin Ltd. on March 26, 2009. | Health Technology |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Finance |
UCB Japan Co. Ltd. | |
NovaMedica LLC
NovaMedica LLC Pharmaceuticals: MajorHealth Technology NovaMedica LLC operates as a pharmaceutical company. Its portfolio includes gastroenterology, ophthalmology, and neurology. The company was founded in 2012 and is headquartered in Moscow, Russian Federation. | Health Technology |
YL Biologics Ltd. | |
Kyowa Criticare Co. Ltd.
Kyowa Criticare Co. Ltd. Medical DistributorsDistribution Services Kyowa Criticare Co. Ltd. manufactures and sells ethical drugs. It also offers contract manufacturing of ethical drugs. The company was founded in April 1941 and is headquartered in Tokyo, Japan. | Distribution Services |